USE OF CLOSTRIDIUM PERFRINGENS STRAIN 23 TO PROTECT AGAINST NECROTIC ENTERITIS

摘要

The present invention relates to the prevention of necrotic enteritis caused by an infection with the anaerobe bacterium Clostridium perfringens. More specifically, the invention relates to compounds produced by or derived from Clostridium perfringens strain 23 which are useful as vaccines to effectively protect against necrotic enteritis.